Dasatinib: SFK inhibitorVandetanib: Src, VEGFR2, EGFR, and Rearranged during transfection (RET) inhibitor.Condition: Diffuse Intrinsic Pontine Glioma. This evidence concerns the gene KDR and central nervous system cancer.